Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
3
Neutral
6
Bullish
5
Bearish
17
Neutral
8
Bullish
21
Bearish
14
Neutral
2
Bullish
16
Achyut Healthcare Limited is primarily involved in trading pharmaceutical products such as drugs, vitamins, and medical equipment, catering to both domestic and international markets.
Despite its focus on pharmaceutical trading, Achyut Healthcare has created a significant market presence in countries like UAE, Kenya, and Nigeria while operating across India.
The company initially started in 1996 as a private limited entity and transitioned to a public limited company in 2021, showcasing its growth trajectory.
Achyut Healthcare raised capital through an IPO in March 2022 by issuing 18,00,000 equity shares, highlighting its intent to expand and strengthen its operations.
Pharmaceuticals & Biotechnology
Pharmaceuticals
164 Cr
Low Risk
513.6
37.7
—
4.7
10.04
4.70
Sales CAGR
Profit CAGR
ROE
ROCE
Achyut Healthcare Ltd (ACHYUT) is currently trading at 6.90 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Achyut Healthcare Limited is primarily involved in trading pharmaceutical products such as drugs, vitamins, and medical equipment, catering to both domestic and international markets. Despite its focus on pharmaceutical trading, Achyut Healthcare has created a significant market presence in countries like UAE, Kenya, and Nigeria while operating across India. The company initially started in 1996 as a private limited entity and transitioned to a public limited company in 2021, showcasing its growth trajectory. Achyut Healthcare raised capital through an IPO in March 2022 by issuing 18,00,000 equity shares, highlighting its intent to expand and strengthen its operations.
Over the past 52 weeks, Achyut Healthcare Ltd has traded between a low of ₹4.70 and a high of ₹10.04. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Achyut Healthcare Ltd has a market capitalization of approximately 164.36. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Achyut Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 513.63 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 164.36 Cr, Achyut Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Achyut Healthcare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Achyut Healthcare Ltd is 513.63. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Trading on the BSE Main Board is set to begin on January 02, 2026, after BSE approved the company’s migration from the SME platform.
Zenith Life Care Private Limited acquired 2,00,000 equity shares in Achyut Healthcare through a preferential allotment dated March 23, 2026.
Achyut Healthcare Ltd’s closing price as of Jul 13, 2026 (04:01 PM) was ₹7.91.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
134.37 | 174 Cr | 12.01 | 1.55 | 0.00 | 11.71 | 15.56 | 11.21 | ||
31.50 | 171 Cr | 27.79 | 1.19 | 0.00 | 8.93 | 13.60 | 2.10 | ||
6.90 | 164 Cr | 513.63 | 4.69 | 0.00 | 0.90 | 1.13 | 0.84 | ||
218.65 | 161 Cr | 29.98 | 4.29 | 0.00 | 0.00 | 0.00 | 0.00 | ||
259.00 | 160 Cr | 34.12 | 3.72 | 0.00 | 4.47 | 7.31 | 1.55 | ||
10.26 | 156 Cr | 51.86 | 13.14 | 0.00 | 15.34 | 21.17 | 8.18 | ||
114.02 | 151 Cr | 20.87 | 1.84 | 1.26 | 7.64 | 9.18 | 1.93 | ||
| Median: 7 Co. | — | 114.02 | 161 Cr | 29.98 | 3.72 | 0.00 | 7.64 | 9.18 | 1.93 |
AGM/EGM Notice
Achyut Healthcare Ltd notifies cut-off date for 31st AGM as 2026-09-22; e-voting from 2026-09-26 09:00 to 2026-09-28 17:00; AGM on 2026-09-29.
Board Meeting
Achyut Healthcare Ltd: Board on 2026-09-05 approved AGM notice; AGM to be held 2026-09-29 at 10:30 via VC/OAVM; record date 2026-09-22; appointed scrutinizers; recommended reappointments of MD Jigen J. Modi and two independent directors (w.e.f. 2026-11-01) subject to shareholder approval.
AGM/EGM Notice
Achyut Healthcare Ltd: Notice of 31st AGM to be held on 29-09-2026 at 10:30 AM via VC/OAVM to adopt FY 2025-26 financials and consider re-appointments including Managing Director and independent directors.
